Quality of reporting of randomised controlled trials of artificial intelligence in healthcare: a systematic review
Objectives The aim of this study was to evaluate the quality of reporting of randomised controlled trials (RCTs) of artificial intelligence (AI) in healthcare against Consolidated Standards of Reporting Trials—AI (CONSORT-AI) guidelines.Design Systematic review.Data sources We searched PubMed and EM...
Main Authors: | M A Rehman Siddiqui, Rida Shahzad, Bushra Ayub |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/9/e061519.full |
Similar Items
-
Artificial Intelligence and the Future of Healthcare in Pakistan: Opportunities and Challenges
by: Rehman Siddiqui, et al.
Published: (2023-09-01) -
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines
by: Alexander P. L. Martindale, et al.
Published: (2024-02-01) -
Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol
by: Paul Hofman, et al.
Published: (2024-02-01) -
Quality of reporting inflammatory bowel disease randomised controlled trials: a systematic review
by: Morris Gordon, et al.
Published: (2024-04-01) -
Adherence of randomised controlled trials using artificial intelligence in ophthalmology to CONSORT-AI guidelines: a systematic review and critical appraisal
by: Tina Felfeli, et al.
Published: (2023-12-01)